MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
EBS Cash Flow Sankey Diagram
Sankey diagram visualizing EBS cash flow for the period
Impairment of long-lived
assets
$191,300K
Inventories
-$24,000K
(-189.22%↓ Y/Y)
Depreciation and
amortization
$24,000K
(-50.92%↓ Y/Y)
Other
-$23,700K
(-360.44%↓ Y/Y)
Noncash loss on assets
held-for-sale
-$10,700K
(12.30%↑ Y/Y)
Accounts payable
$10,000K
(163.29%↑ Y/Y)
Stock-based compensation
expense
$6,900K
(13.11%↑ Y/Y)
Accrued compensation
$4,200K
(115.97%↑ Y/Y)
Contract liabilities
$3,300K
(3400.00%↑ Y/Y)
Accrued expenses and
other liabilities
$3,000K
(110.60%↑ Y/Y)
Deferred income taxes
$2,100K
(-55.32%↓ Y/Y)
Amortization of deferred
financing costs
$1,600K
(-65.96%↓ Y/Y)
Loss on disposal of
assets
-$1,200K
(7.69%↑ Y/Y)
Net cash provided by
operating activities
$56,100K
(-41.07%↓ Y/Y)
Canceled cashflow
$249,900K
Net change in cash,
cash equivalents and...
-$20,600K
(-112.45%↓ Y/Y)
Canceled cashflow
$56,100K
Proceeds from sale of
property, plant and...
$200K
(-99.48%↓ Y/Y)
Proceeds from the
issuance of debt, net of...
$145,500K
Proceeds from
stock-based compensation...
$1,400K
(75.00%↑ Y/Y)
Net income (loss)
-$180,200K
(-421.79%↓ Y/Y)
Accounts receivable
$68,800K
(252.21%↑ Y/Y)
Change in fair value of
warrant liability
-$500K
(92.42%↑ Y/Y)
Income taxes
receivable and payable, net
-$300K
(81.25%↑ Y/Y)
Prepaid expenses and
other assets
$100K
(100.34%↑ Y/Y)
Net cash provided by
(used in) investing...
-$52,300K
(-168.19%↓ Y/Y)
Canceled cashflow
$200K
Net cash used in
financing activities
-$24,400K
(-258.82%↓ Y/Y)
Canceled cashflow
$146,900K
Milestone payment from
prior asset...
$50,400K
Purchases of property,
plant and equipment
$2,100K
(-67.69%↓ Y/Y)
Repayment of prior term
loan facility
$150,000K
Debt issuance and
extinguishment costs
$11,500K
Purchases of treasury
stock
$9,000K
(30.43%↑ Y/Y)
Taxes paid for
stock-based compensation...
$400K
(-42.86%↓ Y/Y)
Back
Back
Emergent BioSolutions Inc. (EBS)
Emergent BioSolutions Inc. (EBS)
Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com